Eton Pharmaceuticals, Inc. (ETON): Price and Financial Metrics

Eton Pharmaceuticals, Inc. (ETON): $14.41

0.13 (+0.91%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add ETON to Watchlist
Sign Up

ETON Price/Volume Stats

Current price $14.41 52-week high $15.00
Prev. close $14.28 52-week low $3.03
Day low $14.14 Volume 336,400
Day high $14.87 Avg. volume 325,327
50-day MA $11.97 Dividend yield N/A
200-day MA $6.40 Market Cap 375.39M

ETON Stock Price Chart Interactive Chart >


Eton Pharmaceuticals, Inc. (ETON) Company Bio


Eton Pharmaceuticals Inc. Eton Pharmaceuticals, Inc. is a is a specialty pharmaceutical company, which is focused on developing and commercializing pharmaceutical products. It products include EM-100, ET-103, CT-100, DS-300, DS-200, and DS-100. The Company focuses on product candidates that are liquid in formulation, including injections, oral liquids and ophthalmics. EM-100 is an ophthalmic product with a preservative-free formulation of the active ingredient ketotifen, and is indicated for the treatment of allergic conjunctivitis. ET-103 is an oral liquid formulation of levothyroxine, which is widely used in tablet and capsule form, and is indicated for the treatment of hypothyroidism. CT-100 is our patent-pending synthetic corticotropin therapeutic candidate that mimics the amino acid chain of injectable product H.P. Acthar Gel. DS-300 is a patent-pending injectable product candidate indicated to treat nutritional deficiencies. DS-200 is an injectable product candidate indicated to treat pain management.


ETON Latest News Stream


Event/Time News Detail
Loading, please wait...

ETON Latest Social Stream


Loading social stream, please wait...

View Full ETON Social Stream

ETON Price Returns

1-mo 14.64%
3-mo 77.24%
6-mo 303.64%
1-year 228.25%
3-year 308.22%
5-year 114.75%
YTD 8.18%
2024 204.11%
2023 55.32%
2022 -34.27%
2021 -47.23%
2020 12.92%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!